REXAHN PHARMACEUTICALS, INC. Business Finance Contracts & Agreements

117 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Purchase Agreement between Iveric Bio Gene Therapy LLC and Opus Genetics Inc.
Purchase Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2025
Assignment Consent Agreement and Third Amendment to Exclusive License Agreement among Iveric bio Gene Therapy LLC, Opus Genetics Inc., University of Pennsylvania, and University...
Assignment Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2025
Description of Opus Genetics, Inc. Securities Registered Under Section 12 of the Exchange Act
Stock Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2025
Pre-Funded Common Stock Purchase Warrant Agreement between Opus Genetics, Inc. and Holder
Warrant Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2025
Common Stock Purchase Warrant Agreement between Opus Genetics, Inc. and Holder
Warrant Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2025
Opus Genetics, Inc. Underwriting Agreement with Craig-Hallum Capital Group LLC (March 21, 2025)
Underwriting Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2025
Opus Genetics, Inc. Sales Agreement with Leerink Partners LLC for Common Stock Offering
Equity Distribution Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2025
Registration Rights Agreement between Ocuphire Pharma, Inc. and Lincoln Park Capital Fund, LLC (August 10, 2023)
Registration Rights Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
IL
2023
Purchase Agreement between Ocuphire Pharma, Inc. and Lincoln Park Capital Fund, LLC (August 10, 2023)
Purchase Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2023
Ocuphire Pharma, Inc. Stock Option Grant Notice and Option Agreement (2021 Inducement Plan)
Stock Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2023
Ocuphire Pharma, Inc. Stock Option Grant Notice and Agreement (2020 Equity Incentive Plan)
Stock Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
DE
2023
Ocuphire Pharma, Inc. RSU Award Grant Notice and Agreement (2020 Equity Incentive Plan)
Equity Distribution Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2023
Purchase Agreement between Ocuphire Pharma, Inc. and Investors for Common Stock and Warrants
Purchase Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2021
Common Stock Purchase Warrant Agreement between Ocuphire Pharma, Inc. and Holder (June 8, 2021)
Warrant Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2021
Ocuphire Pharma, Inc. Placement Agent Agreement with A.G.P./Alliance Global Partners (June 2021)
Underwriting Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2021
Purchase Agreement between Ocuphire Pharma, Inc. and Investors for Common Stock and Warrants
Purchase Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2021
Common Stock Purchase Warrant Agreement between Ocuphire Pharma, Inc. and Holder (June 8, 2021)
Warrant Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2021
Placement Agent Agreement between Ocuphire Pharma, Inc. and A.G.P./Alliance Global Partners (June 4, 2021)
Equity Distribution Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2021
Ocuphire Pharma, Inc. Capital on Demand™ Sales Agreement with JonesTrading Institutional Services LLC (March 11, 2021)
Equity Distribution Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2021
Description of Rexahn Pharmaceuticals, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2021
Waiver Agreement between Ocuphire Pharma, Inc. and Holders of Warrants (February 3, 2021)
Waiver Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2021
Contingent Value Rights Agreement among Rexahn Pharmaceuticals, Shareholder Representative Services, and Olde Monmouth Stock Transfer
Stock Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
DE
2020
Warrant Exchange Agreement between Rexahn Pharmaceuticals, Inc. and Holder (September 10, 2020)
Warrant Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
DE
2020
Warrant Exchange Agreement between Rexahn Pharmaceuticals, Inc. and Warrant Holder (September 10, 2020)
Warrant Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
DE
2020
Warrant Exchange Agreement between Rexahn Pharmaceuticals, Inc. and Holder (September 10, 2020)
Warrant Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
DE
2020
Warrant Exchange Agreement between Rexahn Pharmaceuticals, Inc. and Warrant Holder (September 1, 2020)
Warrant Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
DE
2020
Warrant Exchange Agreement between Rexahn Pharmaceuticals, Inc. and Holder (July 31, 2020)
Warrant Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
DE
2020
Conversion Agreement between Ocuphire Pharma, Inc. and Noteholders Regarding Automatic Note Conversion Prior to Merger
Modification Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
DE
2020
First Amendment to Amended and Restated Mezz Note Purchase Agreement and Mezz Convertible Subordinated Promissory Notes by Ocuphire Pharma, Inc. and Purchasers
Note Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
DE
2020
Amended and Restated Mezzanine Note Purchase Agreement between Ocuphire Pharma, Inc. and Purchasers (January 22, 2019)
Note Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
MI
2020
Ocuphire Pharma, Inc. Stock Option Grant Notice under 2018 Equity Incentive Plan
Warrant Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2020
Ocuphire Pharma, Inc. 2018 Equity Incentive Plan
Equity Distribution Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
DE
2020
First Amendment to Sublicense Agreement between Apexian Pharmaceuticals, Inc. and Ocuphire Pharma, Inc.
Modification Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
MI
2020
Stockholders Agreement of Ocuphire Pharma, Inc. dated April 10, 2018
Shareholders Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
MI
2020
Lock-Up Agreement between Rexahn Pharmaceuticals, Inc., Ocuphire Pharma, Inc., and Stockholder (2020)
Financing Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Amended and Restated Securities Purchase Agreement among Ocuphire Pharma, Rexahn Pharmaceuticals, and Investors (June 29, 2020)
Purchase Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Ocuphire Pharma, Inc. Series A/B Warrant to Purchase Common Stock
Warrant Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Lock-Up Agreement among Rexahn Pharmaceuticals, Inc., Ocuphire Pharma, Inc., and Stockholder
Waiver Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Securities Purchase Agreement among Ocuphire Pharma, Inc., Rexahn Pharmaceuticals, Inc., and Investors (June 17, 2020)
Purchase Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Registration Rights Agreement between Rexahn Pharmaceuticals, Inc. (to be renamed Ocuphire Pharma, Inc.) and Investors – June 17, 2020
Registration Rights Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2020